Eli Lilly and Company (FRA:LLY)
564.50
+1.30 (0.23%)
Last updated: Aug 14, 2025
Eli Lilly and Company Revenue
Eli Lilly and Company had revenue of $15.56B USD in the quarter ending June 30, 2025, with 37.64% growth. This brings the company's revenue in the last twelve months to $53.26B, up 36.83% year-over-year. In the year 2024, Eli Lilly and Company had annual revenue of $45.04B with 32.00% growth.
Revenue (ttm)
$53.26B
Revenue Growth
+36.83%
P/S Ratio
11.16
Revenue / Employee
$1.13M
Employees
47,000
Market Cap
506.14B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 45.04B | 10.92B | 32.00% |
Dec 31, 2023 | 34.12B | 5.58B | 19.56% |
Dec 31, 2022 | 28.54B | 223.00M | 0.79% |
Dec 31, 2021 | 28.32B | 3.78B | 15.40% |
Dec 31, 2020 | 24.54B | 2.22B | 9.95% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.89B |
Siemens Aktiengesellschaft | 78.30B |
Deutsche Telekom AG | 120.55B |
Allianz SE | 123.69B |
Siemens Energy AG | 38.39B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
Rheinmetall AG | 10.67B |
Deutsche Bank Aktiengesellschaft | 30.07B |
Eli Lilly and Company News
- 23 hours ago - Viking's Oral Obesity Drug Poised To Gain Ground After Eli Lilly's Orforglipron Setback: Analyst - Benzinga
- 23 hours ago - Viking's Oral Obesity Drug Poised To Gain Ground After Eli Lilly's Orforglipron Setback: Analyst - Benzinga
- 1 day ago - SA analyst upgrades/downgrades: TSLA, LLY, MSFT, NBIS - Seeking Alpha
- 1 day ago - We're double upgrading Eli Lilly after the CEO and other insiders scoop up the slumping stock - CNBC
- 1 day ago - Eli Lilly Board Member Makes $1.01M Stock Purchase - Benzinga
- 1 day ago - EVP Of Eli Lilly Purchased $634K In Stock - Benzinga
- 1 day ago - Smart Money Move: David A Ricks Grabs $1.05M Worth Of Eli Lilly Stock - Benzinga
- 1 day ago - Nvidia To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga